Life Tech Eyes Long-Term Opportunities in Synthetic Bio Space | GenomeWeb

By Tony Fong

NEW YORK (GenomeWeb News) – With two recent deals, Life Technologies is positioning itself to capitalize on what could be the next big market opportunity in the life sciences.

During the past two weeks the Carlsbad, Calif.-based company has completed two deals giving it a seat at the synthetic biology table — a field with a market size that has been projected to reach $2.4 billion by 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.